Rare but life-threatening aspiration pneumonia related to initiation of clobazam therapy

Clobazam (CLB) was approved in October 2011 by the United States FDA as an adjunctive therapy for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients older than the age of 2. Due to its unique chemical design and selective binding to the alpha-2 GABA-receptor, CLB has...

Descripción completa

Detalles Bibliográficos
Autores principales: Aung, Thandar, Shvarts, Vladimir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720012/
https://www.ncbi.nlm.nih.gov/pubmed/33313501
http://dx.doi.org/10.1016/j.ebr.2020.100406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720012/
https://www.ncbi.nlm.nih.gov/pubmed/33313501
http://dx.doi.org/10.1016/j.ebr.2020.100406

Ejemplares similares